Philip Morris International seeks FDA approval to keep marketing IQOS as reduced risk product (PM:NYSE)

Philip Morris International (NYSE:PM) is urging the U.S. Food and Drug Administration to allow the company to continue marketing its heated tobacco products in the U.S. as a “modified risk tobacco product.” By heating tobacco instead of burning it, Philip Morris ( ...